does tirzepatide affect your heart Mechanisms of action, benefits, and risks of in CVDs Tirzepatide Heart Health: Clinical Evidence

Data availability The datasets generated and analysed during the current study are not publicly available due to the restrictions imposed by ethical and data protection regulations

Proper storage includes keeping the medication in a dry, dim place, ensuring the pen cap is closed after use, and safely disposing of the pen after its expiration date

Many patients maintain weight loss through lifestyle strategies and sometimes continue low-dose maintenance therapy to prevent rebound weight gain

Use of aggregate data limits the possibility to investigate subgroups of patients and suggest caution about the observed differences in treatment effects between subgroups (with or without pre-existing CV disease)

GLP-1 medications are contraindicated or require careful evaluation in these situations: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) History of pancreatitis Severe gastroparesis or other conditions where slowed gastric emptying is dangerous Pregnancy or planning to become pregnant

The Cochrane Collaboration (2008)